ISSN 2147-9720 | E-ISSN 2148-4279
Familial Mediterranean fever: An updated review
(Eur J Rheumatol 2014; 1: 21-33)
DOI: 10.5152/eurjrheum.2014.006
An old disease with new insights: Update on diagnosis and treatment of gout
(Eur J Rheumatol 2014; 1: 72-77)
DOI: 10.5152/eurjrheumatol.2014.021
Case Report
Successful treatment of tumor necrosis factor receptor-associated periodic syndrome (TRAPS) with tocilizumab: a case report
(Eur J Rheumatol 2015; 2: 35-36)
DOI: 10.5152/eurjrheumatol.2014.14053
Anakinra use during pregnancy: Report of a case with Familial Mediterranean Fever and infertility
(Eur J Rheumatol 2017; 4: 66-67)
DOI: 10.5152/eurjrheum.2017.16075
Recurrence of proteinuria after cessation of tocilizumab in patients with AA amyloidosis secondary to FMF
(Eur J Rheumatol ; : -)
DOI: 10.5152/eurjrheum.2018.17183
Original Article
The role of MEFV mutations in the concurrent disorders observed in patients with familial Mediterranean fever
(Eur J Rheumatol 2016; 3: 118-121)
DOI: 10.5152/eurjrheum.2016.16012
Evaluation of arterial stiffness with plasma GGT levels and pulse wave velocity measurement in patients with FMF
(Eur J Rheumatol 2014; 1: 11-13)
DOI: 10.5152/eurjrheum.2014.003
Neutrophil-lymphocyte ratio in children with familial Mediterranean fever: original article
(Eur J Rheumatol 2015; 2: 20-23)
DOI: 10.5152/eurjrheumatol.2015.0093
Heart rate variability in familial Mediterranean fever patients
(Eur J Rheumatol 2014; 1: 58-61)
DOI: 10.5152/eurjrheumatol.2014.013
IL1-blocking therapy in colchicine-resistant familial Mediterranean fever
(Eur J Rheumatol ; : -)
DOI: 10.5152/eurjrheum.2018.18036
Immune and inflammatory gene expressions are different in Behçet’s disease compared to those in Familial Mediterranean Fever
(Eur J Rheumatol 2016; 3: 146-152)
DOI: 10.5152/eurjrheum.2016.15099
Real-life experience of using conventional diseasemodifying anti-rheumatic drugs (DMARDs) in psoriatic arthritis (PsA). Retrospective analysis of the efficacy of methotrexate, sulfasalazine, and leflunomide in PsA...
(Eur J Rheumatol 2017; 4: 1-10)
DOI: 10.5152/eurjrheum.2017.1608
The relationship of serum endocan levels and anti-TNF-alpha therapy in patients with ankylosing spondylitis
(Eur J Rheumatol 2018; 5: 1-4)
DOI: 10.5152/eurjrheum.2017.17287
Late ventricular potentials in familial Mediterranean fever with and without AA amyloidosis
(Eur J Rheumatol 2017; 4: 184-188)
DOI: 10.5152/eurjrheum.2017.16113
Serum lipid changes and insulin resistance in familial Mediterranean fever
(Eur J Rheumatol 2014; 1: 140-143)
DOI: 10.5152/eurjrheumatol.2014.140045
Relationship between endothelial dysfunction and microalbuminuria in familial Mediterranean fever
(Eur J Rheumatol 2016; 3: 61-64)
DOI: 10.5152/eurjrheum.2016.15079
Invited Review
Relapsing polychondritis
(Eur J Rheumatol 2015; 2: 155-159)
DOI: 10.5152/eurjrheum.2015.0036
Literature Review
Relationship between diet and ankylosing spondylitis: A systematic review
(Eur J Rheumatol 2018; 5: 45-52)
DOI: 10.5152/eurjrheum.2017.16103
Key Words
Author’s Corner
AVES | Copyright © 2018 Medical Research and Education Association | Latest Update: 27.08.2018